Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients : postmarketing surveillance report of the first 3,000 patients

スポンサーリンク

概要

• 論文の詳細を見る
• 2012-08-01

著者

• Takeuchi Tsutomu

  Keio Univ. School Of Medicine Tokyo Jpn

• Harigai Masayoshi

  Tokyo Medical Dental University Graduate School

• Ishiguro Naoki

  Nagoya University Graduate School Of Medicine

• INOKUMA Shigeko

  Japanese Red Cross Medical Center

• TANAKA Yoshiya

  University of Occupational and Environmental Health

• Yamanaka Hisashi

  Tokyo Women's Medical University

• ISHIGURO Naoki

  Nagoya University School of Medicine

• KOIKE Takao

  Sapporo Medical Center NTT EC

• TAKEI Shuji

  Faculty of Medicine, Kagoshima University School of Health Science

• HARIGAI Masayoshi

  Tokyo Medical and Dental University

関連論文

• Effects of Aphidicolin on Entamoeba histolytica Growth and DNA Synthesis
• Inhibition of Encystation of Entamoeba invadens by Aphidicolin
• Comparison of DNA polymerase between Entamoeba histolytica and E. dispar
• The Effect of Muscle Relaxant on the Paraspinal Muscle Blood Flow : A Randomized Controlled Trial in Patients With Chronic Low Back Pain
• Efficacy and safety of tacrolimus in 101 consecutive patients with rheumatoid arthritis
• Asymptomatic cyst passers of Entamoeba histolytica but not Entamoeba dispar in institutions for the mentally retarded in Japan
• Induction of permeability changes and death of vertebrate cells is modulated by the virulence of Entamoeba spp. isolates
• The application of the atomic force microscope to studies of medically important protozoan parasites
• Interferon-induced helicase (IFIH1) polymorphism with systemic lupus erythematosus and dermatomyositis/polymyositis
• Effect of total knee arthroplasty on disease activity in patients with established rheumatoid arthritis : 3-year follow-up results of combined medical therapy and surgical intervention
• Postmarketing surveillance of tocilizumab for rheumatoid arthritis in Japan: interim analysis of 3881 patients
• Efficacy and tolerability of tocilizumab in rheumatoid arthritis patients seen in daily clinical practice in Japan : results from a retrospective study (REACTION study)
• Humanized anti-interleukin-6-receptor antibody (tocilizumab) monotherapy is more effective in slowing radiographic progression in patients with rheumatoid arthritis at high baseline risk for structural damage evaluated with levels of biomarkers, radiograp
• Serum ferritin correlates with activity of anti-MDA5 antibody-associated acute interstitial lung disease as a complication of dermatomyositis
• Interleukin-18 promoter polymorphisms in Japanese patients with rheumatoid arthritis : protective effect of the T allele and T/T genotype at rs360722
• Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis
• Efficacy and safety of intravenous cyclophosphamide pulse therapy with oral prednisolone in the treatment of interstitial lung disease with systemic sclerosis : 4-year follow-up
• Incidence of falls and fear of falling in Japanese patients with rheumatoid arthritis
• Functional Analysis of Human Sodium-Phosphate Transporter 4 (NPT4/SLC17A3) Polymorphisms
• Identification of an avirulent Entamoeba histolytica strain with unique tRNA-linked short tandem repeat markers
• Safety and effectiveness responses to etanercept for rheumatoid arthritis in Japan: a sub-analysis of a post-marketing surveillance study focusing on the duration of rheumatoid arthritis
• Safety and effectiveness of switching from infliximab to etanercept in patients with rheumatoid arthritis: results from a large Japanese postmarketing surveillance study
• Efficacy of total joint arthroplasty in patients with established rheumatoid arthritis : improved longitudinal effects on disease activity but not on health-related quality of life
• Incidence of serious respiratory infections in patients with rheumatoid arthritis treated with tocilizumab
• Standard treatment in daily clinical practice for early rheumatoid arthritis improved disease activity from 2001 to 2006
• Studies of the efficacy and safety of methotrexate at dosages over 8mg/week using the IORRA cohort database
• Efficacy and safety of additional use of tacrolimus in patients with early rheumatoid arthritis with inadequate response to DMARDs-a multicenter, double-blind, parallel-group trial
• Comparison of characteristics and therapeutic efficacy in rheumatoid arthritis patients treated by rheumatologists and those treated by orthopedic surgeons under a team medicine approach at the same institute
• Structural damages disturb functional improvement in patients with rheumatoid arthritis treated with etanercept
• Effectiveness and safety of adalimumab in Japanese patients with rheumatoid arthritis : retrospective analyses of data collected during the first year of adalimumab treatment in routine clinical practice (HARMONY study)
• A multicenter, open-label, efficacy, pharmacokinetic, and safety study of adalimumab in Japanese patients with ankylosing spondylitis
• Radiological features and therapeutic responses of pulmonary nontuberculous mycobacterial disease in rheumatoid arthritis patients receiving biological agents : a retrospective multicenter study in Japan
• Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients : postmarketing surveillance report of the first 3,000 patients
• Elevation of KL-6 serum levels in clinical trials of tumor necrosis factor inhibitors in patients with rheumatoid arthritis : a report from the Japan College of Rheumatology Ad Hoc Committee for Safety of Biological DMARDs
• A retrospective study of serum KL-6 levels during treatment with biological disease-modifying antirheumatic drugs in rheumatoid arthritis patients : a report from the Ad Hoc Committee for Safety of Biological DMARDs of the Japan College of Rheumatology

もっと見る 閉じる

スポンサーリンク